ArticleCommunications medicine2026

Paired longitudinal tear proteomics reveals persistent ocular surface dysregulation after teprotumumab therapy in thyroid eye disease.

Gabriel Velez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.